These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28943919)

  • 1. BRAF
    Dong SY; Zeng RC; Jin LP; Yang F; Zhang XJ; Yao ZH; Zhang XH; Wang OC
    Oncol Lett; 2017 Oct; 14(4):4122-4134. PubMed ID: 28943919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA
    Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of BRAF
    Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
    Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with
    Li GY; Tan HL; Chen P; Hu HY; Liu M; Ou-Yang DJ; Khushbu RA; Pun D; Li JD; Zhang ZP; Yang Q; Huang P; Chang S
    Cancer Manag Res; 2020; 12():3371-3378. PubMed ID: 32494201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between US-FNAC with BRAF V600E Mutation Analysis and Central Neck Lymph Node Metastasis in cN0 Papillary Thyroid Cancer.
    Li R; Hao J; Zhu Z; Qiao X; Wang L; Zhou Z
    Biomed Res Int; 2021; 2021():9937742. PubMed ID: 34307677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation.
    Han Y; Hou L; Zhao B; Gao L; Li S
    Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.
    Li C; Aragon Han P; Lee KC; Lee LC; Fox AC; Beninato T; Thiess M; Dy BM; Sebo TJ; Thompson GB; Grant CS; Giordano TJ; Gauger PG; Doherty GM; Fahey TJ; Bishop J; Eshleman JR; Umbricht CB; Schneider EB; Zeiger MA
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3702-12. PubMed ID: 23969188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer.
    Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF
    Kurtulmus N; Ertas B; Saglican Y; Kaya H; Ince U; Duren M
    Eur Thyroid J; 2016 Sep; 5(3):195-200. PubMed ID: 27843810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
    Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
    Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF V600E and lymph node metastases in papillary thyroid cancer.
    Chen P; Pan L; Huang W; Feng H; Ouyang W; Wu J; Wang J; Deng Y; Luo J; Chen Y
    Endocr Connect; 2020 Oct; 9(10):999-1008. PubMed ID: 33064665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Younger Than 55 Years Old and
    Lai Y; Gu Y; Yu M; Deng J
    Int J Gen Med; 2023; 16():1403-1414. PubMed ID: 37155469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
    Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
    Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
    Dong Y; Wang D; Luo Y; Chen L; Bai H; Shen Y; Zhang Y; Chen X; Su X; Zhao J; Liu H; Lu J; Yao Z; Zhao Y; He C; Li X
    Oncol Lett; 2021 Mar; 21(3):188. PubMed ID: 33574927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of
    Yu L; Ma L; Tu Q; Zhang YI; Chen Y; Yu D; Yang S
    Oncol Lett; 2015 Jun; 9(6):2633-2638. PubMed ID: 26137119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the correlation between BRAF(V600E) mutation and lymphatic metastases in papillary thyroid cancer staged preoperativelv as N0].
    Gao Q; Zhang W; Wang N; Duan H; Zhou Y; Zhang W; Zhao D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Dec; 29(23):2048-52. PubMed ID: 27101676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.